Target intelligence / Profile preview

Heat-labile enterotoxin B subunit of Escherichia coli (LT-B)

Target
LT-B
Molecular classification
Toxin subunit, Bacterial protein, Cell-surface binding protein, Other
01

Overview

The heat-labile enterotoxin B subunit of Escherichia coli (LT-B) is the pentameric cell-binding component of the AB₅ enterotoxin complex secreted by enterotoxigenic E. coli[1][2][3][4][5][7][8][9]. LT-B forms a highly stable, donut-shaped pentamer that binds with high affinity to GM1-ganglioside receptors on the plasma membrane of mammalian cells, mediating endocytosis and facilitating the entry of the catalytic A subunit, which then raises cAMP to induce watery diarrhea[1][3][5][7][9]. The B subunit itself is nontoxic, but is widely studied for its immunomodulatory properties—including induction of regulatory T cells, immune tolerance, and use as a potent mucosal adjuvant in experimental vaccines[5][7][9]. LT-B is antigenically related to the B subunit of cholera toxin, but distinct by sequence and immunogenicity[3][5]. The gene encoding LT-B is eltB, and its protein structure, function, and ability to modulate host-pathogen interactions are well characterized[2][4][6].

Other names
LT-BEtxBHeat-labile enterotoxin B chaineltBltpBLTP-B
02

Mechanism of action

Binds to GM1-ganglioside receptors on mammalian cells, enabling endocytosis and delivery of the catalytic A subunit[7][9]. - As a vaccine adjuvant, enhances immune response by promoting antigen uptake and modulating T cell activity[5][9].

03

Biological functions

Toxin binding and cell entryImmune modulation (adjuvant activity, Treg induction)Pathogenesis (facilitates delivery of A subunit into host cells)
04

Disease associations

Infection (diarrheal diseases)Immune disorders (experimental adjuvant, immune modulator, roles in autoimmunity models)Other
05

Safety considerations

When not separated from the toxic A subunit, can cause severe secretory diarrhea (as in natural infection)[1][5].Potential unwanted immune activation or modulation when used as an adjuvant[5][9].
06

Interacting drugs

None formally approved; experimental immunomodulators and recombinant conjugates (not classical ‘drugs’)
07

Biomarkers

GM1 ganglioside expression (marker for target cell susceptibility)Used experimentally as a marker for mucosal immunity induction

Beyond the preview

Go deeper on Heat-labile enterotoxin B subunit of Escherichia coli (LT-B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat-labile enterotoxin B subunit of Escherichia coli (LT-B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call